Cargando…
Rosiglitazone-Induced Mitochondrial Biogenesis in White Adipose Tissue Is Independent of Peroxisome Proliferator-Activated Receptor γ Coactivator-1α
BACKGROUND: Thiazolidinediones, a family of insulin-sensitizing drugs commonly used to treat type 2 diabetes, are thought to exert their effects in part by promoting mitochondrial biogenesis in white adipose tissue through the transcriptional coactivator PGC-1α (Peroxisome Proliferator-Activated Rec...
Autores principales: | Pardo, Rosario, Enguix, Natàlia, Lasheras, Jaime, Feliu, Juan E., Kralli, Anastasia, Villena, Josep A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3210129/ https://www.ncbi.nlm.nih.gov/pubmed/22087241 http://dx.doi.org/10.1371/journal.pone.0026989 |
Ejemplares similares
-
Antitumor action of the peroxisome proliferator-activated receptor-γ agonist rosiglitazone in hepatocellular carcinoma
por: BO, QI-FU, et al.
Publicado: (2015) -
Mitochondrial Biogenesis and Peroxisome Proliferator–Activated Receptor-γ Coactivator-1α (PGC-1α) Deacetylation by Physical Activity: Intact Adipocytokine Signaling Is Required
por: Li, Ling, et al.
Publicado: (2011) -
Cardiac-Specific Overexpression of ERRγ in Mice Induces Severe Heart Dysfunction and Early Lethality
por: Lasheras, Jaime, et al.
Publicado: (2021) -
Peroxisome biogenesis disorders
por: Argyriou, Catherine, et al.
Publicado: (2016) -
Peroxisome biogenesis and human peroxisome-deficiency disorders
por: FUJIKI, Yukio
Publicado: (2016)